Why Depomed (DEPO) Stock Is Surging Today
The pharmaceutical company also reported earnings for its most recent quarter, coming in at 12 cents a share. The consensus estimate called for 17 cents a share.
Depomed's full-year guidancce has been slightly altered, moving from in the range of $485 million to $525 million, to the range of $490 million to $520 million.
DEPO stock is up 14.7% Monday.
More From InvestorPlace
- Hillary Clinton vs. Donald Trump - Which Stocks Win?
- 31 Index Funds That Are Robbing You Blind
- 7 Blue Chips That Are Getting Ugly in a Hurry